Cost Trends | Express Scripts

Cost Trends

MAC Pricing Keeps Generics Affordable

The market for purchasing drugs can be complex, but with MAC pricing, multi-sourced generic medications are kept as affordable as possible in the U.S.

Biosimilars in the U.S.: More Approvals But Not More Access

Biosimilars have the potential to significantly reduce treatment costs. We take a look at the growing biosimilar pathway.

We Offered a Path to Lower Drug Prices And Gilead Listened

We're encouraged that Gilead Sciences is taking meaningful action to bring prices down for cash-paying customers.

A Call for A Consensus: Price Increases in Branded Drugs Are Unsustainable

Since 2008, brand medications have risen in price an average 232%. We need to work with pharma and the government for common-sense legislation and regulatory changes.

Biologic Manufacturers Should Disclose Patent Settlements to the Federal Government

Express Scripts joined a wide range of health care stakeholders in endorsing legislation.

Copay Accumulator Programs Level the Out-of-Pocket Playing Field

We believe all patients should have access to affordable prescriptions and care, not just those using a medication with drug maker copay assistance.